These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30905285)

  • 1. CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage.
    Common J; Morley D; Westra ER; van Houte S
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180098. PubMed ID: 30905285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the durability of CRISPR-Cas immunity.
    Chabas H; Nicot A; Meaden S; Westra ER; Tremblay DM; Pradier L; Lion S; Moineau S; Gandon S
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180097. PubMed ID: 30905283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of CRISPR-Cas-mediated resistance in Streptococcus thermophilus.
    Vale PF; Lafforgue G; Gatchitch F; Gardan R; Moineau S; Gandon S
    Proc Biol Sci; 2015 Aug; 282(1812):20151270. PubMed ID: 26224708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR immunity drives rapid phage genome evolution in Streptococcus thermophilus.
    Paez-Espino D; Sharon I; Morovic W; Stahl B; Thomas BC; Barrangou R; Banfield JF
    mBio; 2015 Apr; 6(2):. PubMed ID: 25900652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction-modification and CRISPR-Cas.
    Gurney J; Pleška M; Levin BR
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180096. PubMed ID: 30905282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity.
    Levin BR; Moineau S; Bushman M; Barrangou R
    PLoS Genet; 2013; 9(3):e1003312. PubMed ID: 23516369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endless battle between phages and CRISPR-Cas systems in
    Philippe C; Moineau S
    Biochem Cell Biol; 2021 Aug; 99(4):397-402. PubMed ID: 33534660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of CRISPR-Independent Phage Resistance Mechanisms Reveals a Role for FtsH in Phage Adsorption to Streptococcus thermophilus.
    Garrett SC; Philippe C; Kim JG; Wei Y; Johnson KA; Olson S; Graveley BR; Terns MP
    J Bacteriol; 2023 Jun; 205(6):e0048222. PubMed ID: 37255445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical model of the immune response of bacteria against bacteriophage through the adaptive CRISPR-Cas immune system.
    Han P; Niestemski LR; Barrick JE; Deem MW
    Phys Biol; 2013 Apr; 10(2):025004. PubMed ID: 23492852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages.
    Hynes AP; Villion M; Moineau S
    Nat Commun; 2014 Jul; 5():4399. PubMed ID: 25056268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host diversity limits the evolution of parasite local adaptation.
    Morley D; Broniewski JM; Westra ER; Buckling A; van Houte S
    Mol Ecol; 2017 Apr; 26(7):1756-1763. PubMed ID: 27862566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquaculture as a source of empirical evidence for coevolution between CRISPR-Cas and phage.
    Hoikkala V; Almeida GMF; Laanto E; Sundberg LR
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180100. PubMed ID: 30905289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-induced distributed immunity in microbial populations.
    Childs LM; England WE; Young MJ; Weitz JS; Whitaker RJ
    PLoS One; 2014; 9(7):e101710. PubMed ID: 25000306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting natural adaptation of the Streptococcus thermophilus CRISPR-Cas systems in research and classroom settings.
    Hynes AP; Lemay ML; Trudel L; Deveau H; Frenette M; Tremblay DM; Moineau S
    Nat Protoc; 2017 Mar; 12(3):547-565. PubMed ID: 28207002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity.
    Chevallereau A; Meaden S; van Houte S; Westra ER; Rollie C
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180094. PubMed ID: 30905293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity.
    Landsberger M; Gandon S; Meaden S; Rollie C; Chevallereau A; Chabas H; Buckling A; Westra ER; van Houte S
    Cell; 2018 Aug; 174(4):908-916.e12. PubMed ID: 30033365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriostatic antibiotics promote CRISPR-Cas adaptive immunity by enabling increased spacer acquisition.
    Dimitriu T; Kurilovich E; Łapińska U; Severinov K; Pagliara S; Szczelkun MD; Westra ER
    Cell Host Microbe; 2022 Jan; 30(1):31-40.e5. PubMed ID: 34932986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage-induced expression of CRISPR-associated proteins is revealed by shotgun proteomics in Streptococcus thermophilus.
    Young JC; Dill BD; Pan C; Hettich RL; Banfield JF; Shah M; Fremaux C; Horvath P; Barrangou R; Verberkmoes NC
    PLoS One; 2012; 7(5):e38077. PubMed ID: 22666452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
    Maniv I; Jiang W; Bikard D; Marraffini LA
    J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.